Free Trial

Pulmonx (LUNG) Competitors

Pulmonx logo
$3.14 -0.21 (-6.27%)
As of 02:51 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LUNG vs. BFLY, KIDS, RXST, BVS, AXGN, DCTH, TMCI, NPCE, CLPT, and SMLR

Should you be buying Pulmonx stock or one of its competitors? The main competitors of Pulmonx include Butterfly Network (BFLY), OrthoPediatrics (KIDS), RxSight (RXST), Bioventus (BVS), AxoGen (AXGN), Delcath Systems (DCTH), Treace Medical Concepts (TMCI), NeuroPace (NPCE), ClearPoint Neuro (CLPT), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry.

Pulmonx vs.

Pulmonx (NASDAQ:LUNG) and Butterfly Network (NYSE:BFLY) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, community ranking, analyst recommendations, risk and institutional ownership.

Pulmonx has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pulmonx$87.47M1.45-$60.84M-$1.44-2.18
Butterfly Network$85.63M6.31-$133.70M-$0.29-7.53

91.0% of Pulmonx shares are held by institutional investors. Comparatively, 37.8% of Butterfly Network shares are held by institutional investors. 6.8% of Pulmonx shares are held by company insiders. Comparatively, 25.2% of Butterfly Network shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Pulmonx received 31 more outperform votes than Butterfly Network when rated by MarketBeat users. However, 72.73% of users gave Butterfly Network an outperform vote while only 47.56% of users gave Pulmonx an outperform vote.

CompanyUnderperformOutperform
PulmonxOutperform Votes
39
47.56%
Underperform Votes
43
52.44%
Butterfly NetworkOutperform Votes
8
72.73%
Underperform Votes
3
27.27%

Pulmonx has a net margin of -67.31% compared to Butterfly Network's net margin of -129.25%. Butterfly Network's return on equity of -42.68% beat Pulmonx's return on equity.

Company Net Margins Return on Equity Return on Assets
Pulmonx-67.31% -55.36% -33.53%
Butterfly Network -129.25%-42.68%-30.31%

In the previous week, Pulmonx had 3 more articles in the media than Butterfly Network. MarketBeat recorded 4 mentions for Pulmonx and 1 mentions for Butterfly Network. Butterfly Network's average media sentiment score of 1.67 beat Pulmonx's score of 1.15 indicating that Butterfly Network is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pulmonx
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Butterfly Network
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Pulmonx has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Comparatively, Butterfly Network has a beta of 2.59, meaning that its share price is 159% more volatile than the S&P 500.

Pulmonx currently has a consensus target price of $12.07, indicating a potential upside of 284.44%. Butterfly Network has a consensus target price of $4.00, indicating a potential upside of 83.07%. Given Pulmonx's higher probable upside, equities research analysts clearly believe Pulmonx is more favorable than Butterfly Network.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pulmonx
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
Butterfly Network
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Pulmonx and Butterfly Network tied by winning 9 of the 18 factors compared between the two stocks.

Get Pulmonx News Delivered to You Automatically

Sign up to receive the latest news and ratings for LUNG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LUNG vs. The Competition

MetricPulmonxSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$126.61M$4.50B$5.38B$8.42B
Dividend YieldN/A43.64%5.22%4.11%
P/E Ratio-2.1829.5826.6219.77
Price / Sales1.4568.44392.02116.56
Price / CashN/A51.0838.2534.62
Price / Book1.026.256.814.53
Net Income-$60.84M$68.16M$3.23B$248.18M
7 Day Performance-3.68%18.41%4.05%1.06%
1 Month Performance-30.53%23.13%11.64%14.68%
1 Year Performance-64.24%20.79%17.11%6.87%

Pulmonx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LUNG
Pulmonx
3.5245 of 5 stars
$3.14
-6.3%
$12.07
+284.4%
-62.4%$126.61M$87.47M-2.18250Positive News
BFLY
Butterfly Network
2.7815 of 5 stars
$2.35
+5.2%
$4.00
+70.6%
+122.3%$579.89M$85.63M-5.10460Positive News
KIDS
OrthoPediatrics
4.6164 of 5 stars
$23.27
+5.6%
$35.83
+54.0%
-29.6%$565.16M$204.73M-18.92200Positive News
RXST
RxSight
3.0678 of 5 stars
$13.75
+5.3%
$37.60
+173.5%
-73.5%$558.76M$148.31M-16.57220Positive News
Analyst Upgrade
High Trading Volume
BVS
Bioventus
3.2922 of 5 stars
$6.74
+0.9%
$14.33
+112.7%
+12.2%$552.30M$567.70M-11.051,200Positive News
AXGN
AxoGen
3.4241 of 5 stars
$11.39
+0.3%
$22.60
+98.4%
+86.6%$518.64M$187.34M-35.59450
DCTH
Delcath Systems
3.1205 of 5 stars
$14.45
-2.6%
$22.75
+57.4%
+123.8%$483.11M$37.21M-10.7060News Coverage
Gap Up
TMCI
Treace Medical Concepts
2.3204 of 5 stars
$7.20
+5.6%
$10.16
+41.1%
+35.4%$452.81M$210.82M-7.27250Trending News
NPCE
NeuroPace
1.4895 of 5 stars
$13.37
+3.7%
$15.20
+13.7%
+125.4%$437.91M$79.91M-13.37170
CLPT
ClearPoint Neuro
1.7418 of 5 stars
$13.64
-3.3%
$25.00
+83.3%
+108.6%$381.65M$31.39M-19.77110Gap Down
SMLR
Semler Scientific
2.5738 of 5 stars
$34.84
+0.1%
$71.00
+103.8%
+78.4%$334.36M$56.29M7.10120Options Volume
Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:LUNG) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners